CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Revenue
Diagnostic testing service	$ 0	$ 40,138
Product sales	1,758	0
Total revenue	1,758	40,138
Cost of revenue
Product sales	132,411	0
Total cost of revenue	132,411	0
Gross profit (loss) from continuing operations	(130,653)	40,138
Selling expenses	1,421,409	695,930
Research and development expenses	2,359,593	1,110,329
General and administrative expenses	8,846,963	8,052,281
Impairment of intangible assets	0	2,352,626
Total operating expenses	12,627,965	12,211,166
Operating loss	(12,758,618)	(12,171,028)
Other income	431	260
Loss before income taxes	(12,758,187)	(12,170,768)
Income taxes	0	0
Loss from continuing operations	(12,758,187)	(12,170,768)
Loss from discontinued operations (including loss on disposal of $670,943 for the year ended December 31,2015)	(3,002,136)	(2,487,158)
Net loss	$ (15,760,323)	$ (14,657,926)
Loss per common share from continuing operations - basic and diluted (in dollars per share)	$ (0.45)	$ (0.51)
Loss per common share from discontinued operations - basic and diluted (in dollars per share)	(0.10)	(0.10)
Loss per common share - basic and diluted (in dollars per share)	$ (0.55)	$ (0.61)
Weighted average shares outstanding, basic & diluted (in shares)	28,427,523	24,038,578